Jump to navigation

Medical Testing

Children with mild COVID-19 may not develop antibodies; oral vaccine shows promise in monkey study

Submitted by mike kraft on Wed, 2021-10-20 17:41

Children with mild COVID-19 may not develop antibodies; oral vaccine booster shows promise in monkey study The following is a summary of some recent studies on COVID-19. They include research that warrants further study to corroborate the findings and that have yet to be certified by peer review. Nancy Lapid Reuters

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Children with mild COVID-19 may not develop antibodies; oral vaccine shows promise in monkey study
Log in or register to post comments

CDC tool analyizes breakthrough cases for Pfizer, Moderna, J&J

Submitted by mike kraft on Wed, 2021-10-20 10:06

Chances of getting COVID-19 after a vaccine: CDC tool shows breakthrough cases for Pfizer, Moderna, J&J A new CDC tool visualizes just how well the vaccines work against breakthrough cases and death compared to being unvaccinated. Michael Grothaus Fast Company

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Read more about CDC tool analyizes breakthrough cases for Pfizer, Moderna, J&J
Log in or register to post comments

Three lessons for the pilot program to to scale up home use of Covid-19 rapid tests

Submitted by mike kraft on Fri, 2021-10-15 10:50

3 lessons for the effort to scale up Covid-19 rapid tests The slow and sometimes troubled rollout of a Covid-19 rapid test pilot program offers three key lessons for scaling up the use of the tests. Erin Mershon STAT

Country / Region Tags:

General Topic Tags:

Medical Testing

Public Attitudes

Problem, Solution, SitRep, or ?:

Read more about Three lessons for the pilot program to to scale up home use of Covid-19 rapid tests
Log in or register to post comments

U.S. to lift travel restrictions for fully vaccinated individuals

Submitted by mike kraft on Fri, 2021-10-15 10:24

Covid-19 live updates: FDA advisory panel discusses J&J booster; U.S. to lift travel restrictions for fully vaccinated travelers Assistant White House press secretary Kevin Munoz said the United States will lift travel restrictions for fully vaccinated international travelers on Nov. 8. Washington Post

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about U.S. to lift travel restrictions for fully vaccinated individuals
Log in or register to post comments

FDA unlikely to rule on Merck’s COVID pill before December

Submitted by mike kraft on Thu, 2021-10-14 17:59

FDA unlikely to rule on Merck's COVID pill before December WASHINGTON (AP) — The Food and Drug Administration said Thursday it will ask its outside experts to meet in late November to scrutinize Merck's pill to treat COVID-19. The Nov. 30 meeting means U.S. AP NEWS

WASHINGTON (AP) — The Food and Drug Administration said Thursday it will ask its outside experts to meet in late November to scrutinize Merck’s pill to treat COVID-19.

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about FDA unlikely to rule on Merck’s COVID pill before December
Log in or register to post comments

Covid testing, turnaround times still uneven, a problem for many people who need fast results

Submitted by mike kraft on Thu, 2021-10-14 11:43

Why does it still take so long to get Covid test results? Unpredictable waits can be a problem for people trying to plan travel, return to school from quarantine or get lifesaving treatment. NBC News

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about Covid testing, turnaround times still uneven, a problem for many people who need fast results
Log in or register to post comments

EU starts real-time review of AstraZeneca COVID-19 antibody cocktail

Submitted by mike kraft on Thu, 2021-10-14 11:02

EU starts real-time review of AstraZeneca COVID-19 antibody cocktail Europe's drug regulator said on Thursday it had started a real-time review of AstraZeneca's antibody-based COVID-19 therapy, the first protective shot other than vaccines against coronavirus. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about EU starts real-time review of AstraZeneca COVID-19 antibody cocktail
Log in or register to post comments

Breakthrough infections might not be a big transmission risk. New informaton

Submitted by mike kraft on Wed, 2021-10-13 09:52

Breakthrough infections might not be a big transmission risk. Here's the evidence Are vaccinated people who get COVID as likely to spread the infection as unvaccinated people? Scientists don't think so. NPR.org

Conventional wisdom says that if you're vaccinated and you get a breakthrough infection with the coronavirus, you can transmit that infection to someone else and make that person sick.

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Read more about Breakthrough infections might not be a big transmission risk. New informaton
Log in or register to post comments

New treatments offer hope with vaccines for 'interlocking benefits' against COVID-19

Submitted by mike kraft on Tue, 2021-10-12 11:29

New treatments offer hope with vaccines for 'interlocking benefits' against COVID-19 COVID-19 vaccines offer the best protection against severe illness and death, but new antibody and antiviral treatments offer "interlocking benefits." Karen Weintraub, USA TODAY YahooNews

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Read more about New treatments offer hope with vaccines for 'interlocking benefits' against COVID-19
Log in or register to post comments

WHO is waiting for full data on Merck antiviral pill

Submitted by mike kraft on Tue, 2021-10-12 11:18

WHO says it awaits full data from Merck on antiviral pill The World Health Organization is awaiting full clinical data on the antiviral pill made by Merck & Co Inc to treat mild-to-moderate COVID-19 patients, a WHO spokesperson said on Tuesday, a day after the company said it had applied for U.S. emergency use authorisation. Reuters Reuters

Country / Region Tags:

General Topic Tags:

Medical Testing

Problem, Solution, SitRep, or ?:

Situation Report

Read more about WHO is waiting for full data on Merck antiviral pill
Log in or register to post comments

Pages

Do not show recommendations again this session.